Mesoblast (MESO) Other Working Capital Changes (2014 - 2025)
Mesoblast (MESO) posted Other Working Capital Changes of -$682000.0 for Q1 2023, down 55.35% sequentially from -$439000.0 in Q4 2022, and up 40.44% YoY from -$485628.1 in Q1 2022.
Analysis
Mesoblast (MESO) Other Working Capital Changes (2014 - 2025) Analysis & Trends
Mesoblast has reported Other Working Capital Changes for 8 years, with the latest figure at -$682000.0 in Q1 2023.
- Quarterly Other Working Capital Changes rose 40.44% year-over-year to -$682000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was -$2.2 million (up 30.41% YoY) and the FY2022 annual result came in at -$2.8 million, up 4.88% from the prior year.
- Other Working Capital Changes eased to -$682000.0 in Q1 2023 per MESO's latest filing, from -$439000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.4 million in Q1 2022 and troughed at -$3.3 million in Q4 2021.
- A 5-year average of $294750.0 and a median of $1.0 million in 2020 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2020 and 2021: Other Working Capital Changes plunged 1084.48% in 2020, then soared 86.77% in 2021.
- Over 5 years, Other Working Capital Changes stood at -$360000.0 in 2019, then sank by 118.06% to -$785000.0 in 2020, then soared by 32.74% to -$528000.0 in 2021, then grew by 16.86% to -$439000.0 in 2022, then plunged by 55.35% to -$682000.0 in 2023.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$682000.0, -$439000.0, and -$670000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Mesoblast | 2.24 Bn | 2.14 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -3.02 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Sep 30, 2019 | -164,000.00 |
| Sep 30, 2019 | -164,000.00 |
| Sep 30, 2018 | -251,000.00 |
| Sep 30, 2018 | -251,000.00 |
| Sep 30, 2017 | 1.33 Mn |
| Sep 30, 2017 | 1.33 Mn |
| Sep 30, 2015 | -227,000.00 |
| Sep 30, 2015 | -227,000.00 |
| Sep 30, 2014 | -641,000.00 |
| Sep 30, 2014 | -641,000.00 |